Very sad state of affairs. It will go down as the worst start to...

Very sad state of affairs.
It will go down as the worst start to a year for this Co which was just starting to show a positive
change in sentiment when Bright arrived,

There is some uncertainty in the near term outlook due the (CEO) Bright resignation and the
greater than 50% drop in SP since consolidation reflects that. Without that uncertainty, Q1
could have reasonably been expected to at least hover around the 40 cps.

With the implied near term uncertainty conveyed I await regular updates from management,
to see how the company is tracking in finding a suitable replacement together with updates
on the progress of our Phase II trials. Still a believer, however, with far more trepidation these
days.

The challenge is for the Co to find a suitable replacement and fast, so SH can vindicate any
assumptions of uncertainty; also news on progress of Phase II trials to follow soon after that
would help restore some positive sentiment by SH and give them a reason to believe that
perhaps new positive progress and direction is finally validated. Lets see.